Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
Stopped FDA did not accept sponsor's animal toxicology data to support proposed dosing.
Conditions
Interventions
- DRUG: pomalidomide (CC-4047
Sponsor
Stanford University
Collaborators